259
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The global burden of headache is very large, but knowledge of it is far from complete and needs still to be gathered. Published population-based studies have used variable methodology, which has influenced findings and made comparisons difficult. The Global Campaign against Headache is undertaking initiatives to improve and standardize methods in use for cross-sectional studies. One requirement is for a survey instrument with proven cross-cultural validity. This report describes the development of such an instrument. Two of the authors developed the initial version, which was used with adaptations in population-based studies in China, Ethiopia, India, Nepal, Pakistan, Russia, Saudi Arabia, Zambia and 10 countries in the European Union. The resultant evolution of this instrument was reviewed by an expert consensus group drawn from all world regions. The final output was the Headache-Attributed Restriction, Disability, Social Handicap and Impaired Participation (HARDSHIP) questionnaire, designed for application by trained lay interviewers. HARDSHIP is a modular instrument incorporating demographic enquiry, diagnostic questions based on ICHD-3 beta criteria, and enquiries into each of the following as components of headache-attributed burden: symptom burden; health-care utilization; disability and productive time losses; impact on education, career and earnings; perception of control; interictal burden; overall individual burden; effects on relationships and family dynamics; effects on others, including household partner and children; quality of life; wellbeing; obesity as a comorbidity. HARDSHIP already has demonstrated validity and acceptability in multiple languages and cultures. Modules may be included or not, and others ( eg, on additional comorbidities) added, according to the purpose of the study and resources (especially time) available.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          The global burden of headache: a documentation of headache prevalence and disability worldwide.

          This study, which is a part of the initiative 'Lifting The Burden: The Global Campaign to Reduce the Burden of Headache Worldwide', assesses and presents all existing evidence of the world prevalence and burden of headache disorders. Population-based studies applying International Headache Society criteria for migraine and tension-type headache, and also studies on headache in general and 'chronic daily headache', have been included. Globally, the percentages of the adult population with an active headache disorder are 46% for headache in general, 11% for migraine, 42% for tension-type headache and 3% for chronic daily headache. Our calculations indicate that the disability attributable to tension-type headache is larger worldwide than that due to migraine. On the World Health Organization's ranking of causes of disability, this would bring headache disorders into the 10 most disabling conditions for the two genders, and into the five most disabling for women.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The cost of headache disorders in Europe: the Eurolight project.

            Headache disorders are very common, but their monetary costs in Europe are unknown. We performed the first comprehensive estimation of how economic resources are lost to headache in Europe.   From November 2008 to August 2009, a cross-sectional survey was conducted in eight countries representing 55% of the adult EU population. Participation rates varied between 11% and 59%. In total, 8412 questionnaires contributed to this analysis. Using bottom-up methodology, we estimated direct (medications, outpatient health care, hospitalization and investigations) and indirect (work absenteeism and reduced productivity at work) annual per-person costs. Prevalence data, simultaneously collected and, for migraine, also derived from a systematic review, were used to impute national costs.   Mean per-person annual costs were €1222 for migraine (95% CI 1055-1389; indirect costs 93%), €303 for tension-type headache (TTH, 95% CI 230-376; indirect costs 92%), €3561 for medication-overuse headache (MOH, 95% CI 2487-4635; indirect costs 92%), and €253 for other headaches (95% CI 99-407; indirect costs 82%). In the EU, the total annual cost of headache amongst adults aged 18-65 years was calculated, according to our prevalence estimates, at €173 billion, apportioned to migraine (€111 billion; 64%), TTH (€21 billion; 12%), MOH (€37 billion; 21%) and other headaches (€3 billion; 2%). Using the 15% systematic review prevalence of migraine, calculated costs were somewhat lower (migraine €50 billion, all headache €112 billion annually).   Headache disorders are prominent health-related drivers of immense economic losses for the EU. This has immediate implications for healthcare policy. Health care for headache can be both improved and cost saving. © 2011 The Author(s). European Journal of Neurology © 2011 EFNS.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Lifting the burden: The global campaign against headache.

                Bookmark

                Author and article information

                Journal
                J Headache Pain
                J Headache Pain
                The Journal of Headache and Pain
                Springer
                1129-2369
                1129-2377
                2014
                8 January 2014
                : 15
                : 1
                : 3
                Affiliations
                [1 ]Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway
                [2 ]Department of Neuroscience, Imperial College London, London, UK
                [3 ]Department of Epidemiology, Centre for Public Health, National Institute of Mental Health and Neurosciences, Bangalore, India
                [4 ]Centre of Public Health Research, CRP-Santé, Strassen, Luxembourg
                [5 ]Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
                [6 ]Department of Neurology, Evangelic Hospital, Unna, Germany
                [7 ]University of Duisburg-Essen, Essen, Germany
                [8 ]Department of Neurology, St Josef Hospital, Ruhr University Bochum, Bochum, Germany
                [9 ]Department of Neurology, Chinese PLA General Hospital, Beijing, China
                [10 ]King Abdullah International Medical Research Center, King Saud Ben Abdulaziz University for Health Sciences, National Guard Health Affairs, and Prince Mohammed Ben Abdulaziz Hospital, Ministry of Health, Riyadh, Saudi Arabia
                [11 ]Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa, Ethiopia
                [12 ]Department of Neurology, University of Rochester, Rochester, NY, USA
                [13 ]Chikankata Hospital, Mazabuka, Zambia
                [14 ]Department of Neurology, Baqai Medical University, Karachi, Pakistan
                [15 ]Department of Mental Health and Clinical Psychiatry, Chainama College of Health Sciences, Lusaka, Zambia
                [16 ]Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Kavre, Nepal
                [17 ]Danish Headache Center, Department of Neurology, Glostrup Hospital, University of Copenhagen, 2600, Glostrup, Denmark
                [18 ]Department of Neurology, Universidade Federal de Santa Catarina, Florianópolis, Brazil
                [19 ]Preventive Medicine and Biometrics, Uniformed Services University, Bethesda, MD, USA
                [20 ]Department of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan
                [21 ]Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
                [22 ]Norwegian National Headache Centre, Norwegian University of Science and Technology and St Olavs University Hospital, Trondheim, Norway
                Article
                1129-2377-15-3
                10.1186/1129-2377-15-3
                3906903
                24400999
                69ed95a6-b0ec-406d-848a-1d1682951b23
                Copyright © 2014 Steiner et al.; licensee Springer.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 21 December 2013
                : 2 January 2014
                Categories
                Consensus Article

                Anesthesiology & Pain management
                methodology,diagnostic instrument,epidemiology,global campaign against headache,burden of headache

                Comments

                Comment on this article